StockStory Picks Genpact (G) as Top Small-Cap; GoodRx (GDRX), Flagstar (FLG) Tagged as Sells

On June 5, 2026, equity research firm StockStory identified Genpact (NYSE:G) as a small-cap stock with competitive advantages that could outperform, while issuing sell or underperform ratings on GoodRx (NASDAQ:GDRX) and Flagstar Financial (NYSE:FLG). The analysis noted that limited analyst coverage of small-caps can create mispricing but also higher risk. Genpact, with a market value of $5.57 billion, traded at $32.91 per share, a forward P/E of 7.8. The digital transformation services firm, originally spun off from General Electric, uses AI and data analytics to streamline client operations. GoodRx, the prescription discount platform valued at $965.2 million, was tagged as a sell at $2.86 (forward P/E 8.6). Flagstar Financial, a bank with a $5.88 billion market cap, received a bearish call at $14.09 per share, or 0.7 times forward book value. StockStory did not provide specific catalysts for its ratings.